Text Size A A A

Branded Products

Tell a Friend Print Home » USA » Branded Products

Branded Pharmaceuticals Business

Our branded pharmaceuticals business, Ranbaxy Laboratories Inc. (RLI), is committed to developing a distinguished branded pharmaceutical business. The foundation for establishing the branded business rests on three strategic pillars:

  • Licensing/acquisitions
  • In-house product development
  • Marketing alliances

We are actively looking to acquire more products in order to augment RLI’s product offerings to customers.

An important factor in the growth of our branded business is product development expertise. We have highly advanced capabilities in Novel Drug Delivery Systems (NDDS) that offer new and improved formulations to currently available chemical entities. For example, we have developed a once-daily formulation of the anti-infective Cipro (ciprofloxacin), which we have licensed to Bayer, the original marketer of the drug.

We hope to take advantage of our product development expertise by launching our own proprietary brands, which are currently at various stages of development.

With a well-defined branded product portfolio, we are actively looking for marketing partners with complementary skills and needs.

Our branded prescription division in the US market will expand and grow through our global R&D efforts, continued exploration of NDDS; licensing activities; and mergers and acquisitions. Our commitment to invest significantly in R&D will translate into the development of innovative branded products with a wide range of therapeutic uses.

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.